For: | Park S, Yoon WS, Rim CH. Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints. World J Gastroenterol 2020; 26(4): 393-403 [PMID: 32063688 DOI: 10.3748/wjg.v26.i4.393] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i4/393.htm |
Number | Citing Articles |
1 |
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2021; 28(12): 1031 doi: 10.1002/jhbp.865
|
2 |
Belal Abousaida, Danushka Seneviratne, Bradford S Hoppe, Stephen J Ko, Aroumougame Asaithamby, Francis A Cucinotta, Jessica M Kirwan, Kabir Mody, Beau Toskich, Jonathan B Ashman, Christopher L Hallemeier, Sunil Krishnan. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1169 doi: 10.2147/JHC.S292516
|
3 |
Christina Stengl, Shahrouz Ghafoory, Artur Weidner, Brennah Murphy, Stefan Wölfl. Development of an Artificial 3D Liver Phantom for Analysis of Radiotherapeutic Effects In Vitro. Applied Sciences 2022; 12(21): 10867 doi: 10.3390/app122110867
|
4 |
Sunmin Park, Won Sup Yoon, Mi Hee Jang, Chai Hong Rim. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma. International Journal of Radiation Biology 2020; 96(12): 1541 doi: 10.1080/09553002.2020.1830316
|
5 |
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
|
6 |
P. Giraud, D. Lerouge, I. Latorzeff, X. Mirabel, A. Dohan, P. Mordant, N. Barry de Longchamps. Radiothérapie stéréotaxique des tumeurs primitives extracrâniennes. Cancer/Radiothérapie 2020; 24(6-7): 513 doi: 10.1016/j.canrad.2020.06.020
|
7 |
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge. MiR-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin G1. International Journal of Radiation Biology 2022; 98(1): 11 doi: 10.1080/09553002.2021.1987561
|
8 |
Quan Wang, Xiaoquan Ji, Jing Sun, Wengang Li, Xuezhang Duan, Aimin Zhang. Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis. Journal of Cancer Research and Clinical Oncology 2023; 149(10): 7441 doi: 10.1007/s00432-023-04652-y
|
9 |
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?. International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
|
10 |
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge. Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing Apoptosis. Radiation Research 2021; 195(4) doi: 10.1667/RADE-20-00180.1
|
11 |
Yi Liu, Mu Qi, Lianchang Liu, Mengke Li, Hao Feng, Yuhan Gan, Shumei Ma, Xiaodong Liu. Blocking Adipor1 enhances radiation sensitivity in Hepatoma Carcinoma Cells. Archives of Biochemistry and Biophysics 2022; 718: 109152 doi: 10.1016/j.abb.2022.109152
|
12 |
Kyung Su Kim, Hong-Gyun Wu. Who Will Benefit from Charged-Particle Therapy?. Cancer Research and Treatment 2021; 53(3): 621 doi: 10.4143/crt.2021.299
|
13 |
Chai Hong Rim, Jinsil Seong. Radiotherapy of Liver Cancer. 2021; : 155 doi: 10.1007/978-981-16-1815-4_11
|
14 |
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity. JHEP Reports 2022; 4(8): 100498 doi: 10.1016/j.jhepr.2022.100498
|
15 |
Kangning Meng, Guanzhong Gong, Rui Liu, Shanshan Du, Yong Yin. Advances in gross tumor target volume determination in radiotherapy for patients with hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1346407
|
16 |
Gianluca Cassese, Ho-Seong Han, Jai Young Cho, Hae-Won Lee, Boram Lee, Roberto Ivan Troisi. Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma. Cancers 2022; 14(23): 5997 doi: 10.3390/cancers14235997
|
17 |
Alexander Piening, Anand Swaminath, John Dombrowski, Ryan M. Teague, Noor Al-Hammadi, Jeevin Shahi. Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1290691
|
18 |
Marie Cantaloube, Florence Castan, Morgane Creoff, Jessica Prunaretty, Karl Bordeau, Morgan Michalet, Eric Assenat, Boris Guiu, Georges-Philippe Pageaux, Marc Ychou, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou. Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma. Cancers 2021; 13(19): 4853 doi: 10.3390/cancers13194853
|
19 |
Chai Hong Rim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Victor Lee, Zhao-Chong Zeng, Jinsil Seong. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective. Radiotherapy and Oncology 2020; 148: 73 doi: 10.1016/j.radonc.2020.03.027
|
20 |
Yu Yang, Juxian Sun, Jianqiang Cai, Minshan Chen, Chaoliu Dai, Tianfu Wen, Jinglin Xia, Mingang Ying, Zhiwei Zhang, Xuewen Zhang, Chihua Fang, Feng Shen, Ping An, Qingxian Cai, Jingyu Cao, Zhen Zeng, Gang Chen, Juan Chen, Ping Chen, Yongshun Chen, Yunfeng Shan, Shuangsuo Dang, Wei-Xing Guo, Jiefeng He, Heping Hu, Bin Huang, Weidong Jia, Kexiang Jiang, Yan Jin, Yongdong Jin, Yun Jin, Gong Li, Yun Liang, Enyu Liu, Hao Liu, Wei Peng, Zhenwei Peng, Zhiyi Peng, Yeben Qian, Wanhua Ren, Jie Shi, Yusheng Song, Min Tao, Jun Tie, Xueying Wan, Bin Wang, Jin Wang, Kai Wang, Kang Wang, Xin Wang, Wenjing Wei, Fei-Xiang Wu, Bangde Xiang, Lin Xie, Jianming Xu, Mao-Lin Yan, Yufu Ye, Jinbo Yue, Xiaoxun Zhang, Yu Zhang, Aibin Zhang, Haitao Zhao, Weifeng Zhao, Xin Zheng, Hongkun Zhou, Huabang Zhou, Jun Zhou, Xinmin Zhou, Shu-Qun Cheng, Qiu Li. Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition). Liver Cancer 2024; : 1 doi: 10.1159/000541622
|
21 |
Chai Hong Rim. Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma. Journal of Liver Cancer 2021; 21(2): 113 doi: 10.17998/jlc.2021.05.26
|
22 |
Ibrahim Chamseddine, Yejin Kim, Brian De, Issam El Naqa, Dan G. Duda, John Wolfgang, Jennifer Pursley, Harald Paganetti, Jennifer Wo, Theodore Hong, Eugene J. Koay, Clemens Grassberger. Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy. JCO Clinical Cancer Informatics 2022; (6) doi: 10.1200/CCI.21.00169
|
23 |
Francesco Dionisi, Daniele Scartoni, Francesco Fracchiolla, Irene Giacomelli, Benedetta Siniscalchi, Lucia Goanta, Marco Cianchetti, Giuseppe Sanguineti, Alberto Brolese. Proton therapy in the treatment of hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.959552
|
24 |
Han Ah Lee, Yeon Seok Seo, In-Soo Shin, Won Sup Yoon, Hye Yoon Lee, Chai Hong Rim. Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis. International Journal of Surgery 2022; 104: 106753 doi: 10.1016/j.ijsu.2022.106753
|
25 |
Chai Hong Rim. Response to Letter to the Editor by Johnston and Fotiadis regarding “Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.”. Radiotherapy and Oncology 2021; 154: e6 doi: 10.1016/j.radonc.2020.05.027
|
26 |
Reju George Thomas, Subin Kim, Raveena Nagareddy, Veena Vijayan, Ansuja Mathew Pullickal, Mee Sun Yoon, In Kyu Park, Yong Yeon Jeong. Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy- and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma. Cancer Nanotechnology 2023; 14(1) doi: 10.1186/s12645-023-00182-x
|
27 |
S. Lewis, A. Barry, M.A. Hawkins. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation Size. Clinical Oncology 2022; 34(5): e195 doi: 10.1016/j.clon.2022.02.021
|
28 |
Chai Hong Rim, Won Jae Lee, Bekhzood Musaev, Ten Yakov Volichevich, Ziyayev Yakhyo Pazlitdinovich, Tillysshaykhov Mirzagaleb Nigmatovich, Jae Suk Rim. Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan–Korea Oncology Consortium. International Journal of Environmental Research and Public Health 2022; 19(18): 11727 doi: 10.3390/ijerph191811727
|